Oracle may be closing in on $30B purchase of EMR giant Cerner

Oracle, one of the largest software companies in the world, is closing in on the purchase of Cerner for an estimated $30 billion, the Wall Street Journal reported Thursday.

People familiar with the matter said negotiations could be finalized soon and would be considered the largest ever for Oracle. The move would push the software giant further into the cloud and healthcare spaces as it seeks to compete with the likes of Amazon and Microsoft.

Kansas City, Missouri-based Cerner currently has a market cap of about $23 billion and recently hired former Geisinger CEO and Google Health leader David Feinberg as its chief executive officer.

Oracle, meanwhile, boasts a value of more than $280 billion, making it the second-biggest software venture in the world by revenue and market capitalization.

A deal for Cerner would surpass Oracle’s largest transaction to date, approximately $10 billion it paid to buy enterprise-software firm PeopleSoft in 2005. It also acquired NetSuite, a cloud provider, for $9 billion in 2016.

Read the full story below.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

"The number of non-facility services reimbursed at less than direct costs grew 50% since 2024. The number of services under the MPFS for which reimbursement does not even cover cost likely is much higher than 300 services," the proposed AMA resolution states.

COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.